Viemed Healthcare, Inc. VMD Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 57.6%-1.1pp | 57.5%-1.9pp | 57.9%-2.4pp | 58.3%-2.6pp | 58.7%-2.4pp | |
| Operating margin | 8.2%-0.2pp | 8.5%+0.5pp | 8.3%+0.4pp | 8.7%+1.3pp | 8.4%+0.9pp | |
| Net margin | 5.2%-0.1pp | 5.5%+0.5pp | 5.3%+0.5pp | 5.8%+1.2pp | 5.3%0.0pp | |
| EBITDA margin | 18.5%-0.9pp | 19.1%-0.2pp | 19%-0.4pp | 19.6%+0.3pp | 19.4%-0.1pp | |
| Free cash flow margin | 9%— | 4.4%— | 2.1%— | —— | —— | |
| Returns | ||||||
| Return on equity | 10.7%+0.9pp | 10.9%+1.8pp | 10.5%+1.6pp | 10.8%+2.3pp | 9.8%+0.2pp | |
| Return on assets | 7.9%+0.6pp | 7.9%+1.2pp | 7.3%+0.8pp | 8%+2.0pp | 7.4%0.0pp | |
| Return on invested capital | 11.7%+0.7pp | 12.2%+1.4pp | 10.9%+0.8pp | 11.8%+2.7pp | 11.1%— | |
| Efficiency | ||||||
| Asset turnover | 1.5×+0.1× | 1.4×+0.1× | 1.4×0.0× | 1.4×+0.1× | 1.4×0.0× | |
| Inventory turnover | 25.1×+3.4× | 24.5×+4.2× | 22.4×+3.4× | 22.9×+4.9× | 21.7×+2.3× | |
| Liquidity | ||||||
| Current ratio | 1.2×-0.2× | 1.2×-0.2× | 1.1×-0.2× | 1.5×+0.1× | 1.4×+0.1× | |
| Quick ratio | 1.1×-0.2× | 1.1×-0.2× | 1×-0.2× | 1.4×+0.1× | 1.3×+0.1× | |
| Cash ratio | 0.2×0.0× | 0.3×-0.1× | 0.3×-0.1× | 0.5×+0.3× | 0.3×0.0× | |
| Leverage | ||||||
| Debt-to-equity | 0.1×0.0× | 0.1×+0.1× | 0.2×+0.1× | 0×-0.1× | 0.1×0.0× | |
| Debt-to-assets | 0.1×0.0× | 0.1×0.0× | 0.1×+0.1× | 0×0.0× | 0×0.0× | |
| Net debt / EBITDA | 0.1×+0.1× | 0×+0.3× | 0.3×+0.4× | -0.3×-0.4× | -0.1×-0.1× | |
| Per Share | ||||||
| Book value per share | $3.55+9.8% | $3.47+7.7% | $3.30+7.7% | $3.40+15.5% | $3.24+13.0% | |
| Valuation | ||||||
| Market capitalization | $448.16M+71.3% | $282.47M-9.5% | $263.36M-7.5% | $273.9M+8.0% | $287.72M-21.2% | |
| Enterprise value | $450.83M+74.6% | $284.92M-5.5% | $276.93M-1.3% | $260.77M+1.4% | $284.32M-22.6% | |
| Price / earnings | 30.1×+8.8× | 18.9×-8.8× | 19.3×-7.9× | 19.6×-7.2× | 23.4×-11.9× | |
| Price / sales | 1.6×+0.4× | 1×-0.3× | 1×-0.3× | 1.1×-0.1× | 1.2×-0.6× | |
| Price / book | 3.1×+1.2× | 2×-0.4× | 2×-0.3× | 2×-0.2× | 2.1×-1.0× | |
| EV / EBITDA | 8.5×+2.8× | 5.5×-1.4× | 5.7×-1.0× | 5.5×-0.9× | 6.3×-3.4× | |
| EV / sales | 1.6×+0.5× | 1.1×-0.3× | 1.1×-0.2× | 1.1×-0.2× | 1.2×-0.7× | |
| Free cash flow yield | 5.8%— | 4.2%— | 2%— | —— | —— | |
| Earnings yield | 3.3%-1.4pp | 5.3%+1.7pp | 5.2%+1.5pp | 5.1%+1.4pp | 4.3%+1.4pp | |
| PEG ratio | 1.4×+0.3× | 0.6×-2.2× | 0.6×-1.4× | 0.4×-0.5× | 1.2×+0.7× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Viemed Healthcare, Inc.'s profit margins?
- Viemed Healthcare, Inc. (VMD) runs a 57.6% gross margin and a 8.2% operating margin, with a 5.2% net margin.
- Where do Viemed Healthcare, Inc.'s ratios come from?
- Every ratio is computed from Viemed Healthcare, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
